OS Therapies (OSTX) Debt Ratio (2023 - 2026)
OS Therapies' (OSTX) Debt Ratio was 0.18 for Q1 2026.
Powered by 
Analysis
OS Therapies (OSTX) Debt Ratio (2023 - 2026) Analysis & Trends
For FY2023, Debt Ratio at OS Therapies was 20.85.
- The Q1 2026 figure ranks as the highest quarterly Debt Ratio since Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 0.24 |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 0.52 |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 0.42 |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 0.31 |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 0.00 |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 0.60 |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 0.53 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | OS Therapies | 7.83 Mn | 7.83 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 0.18 |
| Jun 30, 2024 | 12.44 |
| Mar 31, 2024 | 16.91 |
| Dec 31, 2023 | 20.85 |
API Access
OS Therapies Debt Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=debt-ratio&ticker=OSTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "debt-ratio", "ticker": "OSTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=debt-ratio&ticker=OSTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();